SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-135790
Filing Date
2004-08-09
Accepted
2004-08-09 15:18:02
Documents
11
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 d10q.htm 10-Q 222191
2 ASSET PURCHASE AGREEMENT dex22.htm EX-2.2 200736
3 FORM OF 1996 STOCK PLAN FOR SALIX PHARMACEUTICALS dex103.htm EX-10.3 104206
4 SUPPLY AGREEMENT dex1044.htm EX-10.44 153001
5 LICENSE ASSIGNMENT AND CONSENT AGREEMENT dex1045.htm EX-10.45 21672
6 ASSIGNMENT OF TRADEMARKS AGREEMENT dex1046.htm EX-10.46 10777
7 LICENSE AGREEMENT dex1047.htm EX-10.47 45982
8 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8872
9 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9041
10 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3103
11 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3160
  Complete submission text file 0001193125-04-135790.txt   785647
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 04961072
SIC: 2834 Pharmaceutical Preparations